Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation.
about
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts.The proportion of CD16(+)CD14(dim) monocytes increases with tumor cell load in bone marrow of patients with multiple myelomaRegulatory T cell-mediated anti-inflammatory effects promote successful tissue repair in both indirect and direct mannersDissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunitiesNew insights into the molecular pathogenesis of langerhans cell histiocytosis.TRAF6 regulates the effects of polarized maturation of tolerability: Marrow-derived dendritic cells on collagen-induced arthritis in mice.Bone and the innate immune system.Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myelomaAlternative pathways of osteoclastogenesis in inflammatory arthritis.Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts.Non-redundant roles for Th17 and Th22 cells in multiple myeloma clinical correlates.Emerging Roles of Osteoclasts in the Modulation of Bone Microenvironment and Immune Suppression in Multiple MyelomaIdentification and characterization of HLA-A24-specific XBP1, CD138 (Syndecan-1) and CS1 (SLAMF7) peptides inducing antigens-specific memory cytotoxic T lymphocytes targeting multiple myeloma.MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells.ICOS-Ligand Triggering Impairs Osteoclast Differentiation and Function In Vitro and In Vivo.IL17A and IL23R gene polymorphisms affect the clinical features and prognosis of patients with multiple myeloma.Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma.Exosomes in melanoma: a role in tumor progression, metastasis and impaired immune system activity.
P2860
Q33574203-3BD0D654-E18C-4C73-8256-A0001DFE5CC1Q35648024-E1D643C8-19BD-4254-9812-71AB03EA8AACQ36018275-3CB299F0-040A-4005-8BDD-2B866F66D626Q36447553-8310AE30-5600-4901-A68D-4358457B698BQ37589059-28822889-3FC1-4FCC-8092-30CEA5807052Q37701080-4B011938-9B77-4E41-9D78-0F24B420FFAFQ38185586-538FE4FF-89CC-4876-B0D4-65D6E3F0A2D0Q38255161-1A9A02EE-8E50-46DF-A92E-1D838D00E133Q38271156-F639AD38-1A5B-4DB9-B22F-FB1BEF0DAE16Q40134213-D7210341-02DF-4E5F-B0E5-76385BC8F6E9Q40436128-8888AC76-B8A3-4698-8A62-F5525E37268AQ41370609-F0997976-48D9-476C-AAEF-0D892C4CDD05Q47580433-9FCF6BBC-1B14-4B92-9F76-FE67B50C52B1Q47702288-396A22CC-3A9D-4C65-AD53-1EDAA56AAABEQ48261321-6FE9B92E-C36E-4256-97C7-D55A10C8ECC2Q48275402-B7682E35-59DD-45F7-B336-087CC2088CC8Q52726999-ED9CE193-767C-4793-BEDC-9DA2ACDBB898Q54966511-7AD5471F-F9E1-48C4-888E-AEB92AEA5E11
P2860
Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Immature dendritic cells in mu ...... h interleukin-17A stimulation.
@en
Immature dendritic cells in mu ...... h interleukin-17A stimulation.
@nl
type
label
Immature dendritic cells in mu ...... h interleukin-17A stimulation.
@en
Immature dendritic cells in mu ...... h interleukin-17A stimulation.
@nl
prefLabel
Immature dendritic cells in mu ...... h interleukin-17A stimulation.
@en
Immature dendritic cells in mu ...... h interleukin-17A stimulation.
@nl
P2093
P2860
P356
P1476
Immature dendritic cells in mu ...... h interleukin-17A stimulation.
@en
P2093
Annalisa Savonarola
Franco Dammacco
Franco Silvestris
Sabino Ciavarella
Stefania Stucci
P2860
P304
P356
10.1111/BJH.12333
P407
P577
2013-04-18T00:00:00Z